More MDUFMA Guidance: FDA Clarifies Performance Goal Review Clock Rules

FDA will grant PMA sponsors an extension of up to 180 days to respond to major deficiencies, the agency notes in a guidance outlining various device review actions and their impact on FDA fulfillment of user fee performance goals